Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd (SHE:300313) — Stock Price
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd (SHE:300313) is currently trading at CN¥8.45 CNY, up 3.68% today. Over the past 52 weeks, shares have ranged between CN¥6.94 and CN¥10.83. This page tracks Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Xinjiang Tianshan Animal Husbandry Bio-e worth.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd (300313) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥200.29 Million | CN¥137.60 Million | CN¥137.50 Million | CN¥76.35 Million | CN¥107.98 Million |
| Cost of Revenue | CN¥185.47 Million | CN¥155.70 Million | CN¥122.12 Million | CN¥67.06 Million | CN¥105.06 Million |
| Gross Profit | CN¥14.82 Million | CN¥-18.10 Million | CN¥15.38 Million | CN¥9.29 Million | CN¥2.92 Million |
| Research & Development | CN¥1.02 Million | CN¥1.21 Million | CN¥1.64 Million | CN¥565.27K | CN¥1.51 Million |
| SG&A | CN¥7.03 Million | CN¥22.29 Million | CN¥22.01 Million | CN¥15.55 Million | CN¥21.76 Million |
| Total Operating Expenses | CN¥205.47 Million | CN¥43.24 Million | CN¥34.04 Million | CN¥37.53 Million | CN¥31.04 Million |
| Operating Income | CN¥-5.19 Million | CN¥-61.34 Million | CN¥-18.66 Million | CN¥-28.24 Million | CN¥-28.12 Million |
| EBITDA | — | CN¥-43.34 Million | CN¥4.71 Million | CN¥-3.09 Million | CN¥-82.12K |
| EBIT | — | CN¥-52.61 Million | CN¥-8.30 Million | CN¥-16.37 Million | CN¥-14.02 Million |
| Interest Expense | CN¥9.27 Million | CN¥10.79 Million | CN¥11.00 Million | CN¥14.10 Million | CN¥14.53 Million |
| Income Before Tax | CN¥-21.96 Million | CN¥-63.40 Million | CN¥-19.31 Million | CN¥-30.47 Million | CN¥-28.55 Million |
| Income Tax Expense | — | CN¥3.68 Million | CN¥2.78 Million | CN¥1.56 Million | CN¥1.85 Million |
| Net Income | CN¥-27.19 Million | CN¥-65.95 Million | CN¥-22.00 Million | CN¥-31.83 Million | CN¥-27.30 Million |
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥279.63 Million | CN¥248.20 Million | CN¥315.23 Million | CN¥332.15 Million | CN¥842.79 Million |
| Total Current Assets | CN¥101.89 Million | CN¥62.54 Million | CN¥111.06 Million | CN¥117.64 Million | CN¥172.59 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CN¥21.24 Million | CN¥18.84 Million | CN¥20.68 Million | CN¥15.05 Million | CN¥28.07 Million |
| Inventory | CN¥33.59 Million | CN¥18.47 Million | CN¥72.46 Million | CN¥54.17 Million | CN¥28.86 Million |
| Property, Plant & Equipment | — | — | — | — | CN¥80.91 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥235.08 Million | CN¥242.51 Million | CN¥243.24 Million | CN¥237.98 Million | CN¥728.43 Million |
| Total Current Liabilities | CN¥56.20 Million | CN¥195.01 Million | CN¥229.67 Million | CN¥225.76 Million | CN¥272.87 Million |
| Long-term Debt | CN¥30.60 Million | CN¥30.80 Million | — | — | — |
| Net Debt | — | CN¥58.58 Million | CN¥68.30 Million | CN¥48.64 Million | CN¥36.89 Million |
| Total Stockholder Equity | CN¥31.64 Million | CN¥-3.78 Million | CN¥62.17 Million | CN¥84.26 Million | CN¥104.13 Million |
| Retained Earnings | CN¥-515.47 Million | CN¥-488.29 Million | CN¥-422.34 Million | CN¥-400.25 Million | CN¥-368.40 Million |
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥1.95 Million | CN¥14.36 Million | CN¥-13.75 Million | CN¥-7.57 Million | CN¥-35.06 Million |
| Capital Expenditures | CN¥6.18 Million | CN¥2.68 Million | CN¥1.65 Million | CN¥1.65 Million | CN¥2.09 Million |
| Free Cash Flow | CN¥-4.24 Million | CN¥11.67 Million | CN¥-15.39 Million | CN¥-9.22 Million | CN¥-37.15 Million |
| Investing Cash Flow | — | CN¥149.07K | CN¥711.75K | CN¥-659.23K | CN¥163.57 Million |
| Financing Cash Flow | — | CN¥-6.74 Million | CN¥-17.52 Million | CN¥-55.38 Million | CN¥-31.13 Million |
| Dividends Paid | CN¥4.51 Million | CN¥5.16 Million | CN¥5.49 Million | CN¥8.79 Million | CN¥10.61 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥13.50 Million | CN¥13.46 Million | CN¥14.87 Million | CN¥14.83 Million | CN¥15.46 Million |
| Change in Cash | CN¥14.89 Million | CN¥7.77 Million | CN¥-30.55 Million | CN¥-61.59 Million | CN¥92.58 Million |
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | 0.02 | — | — |
| Dec 31, 2025 | -0.05 | — | — |
| Sep 30, 2025 | -0.01 | — | — |
| Jun 30, 2025 | -0.01 | — | — |
| Apr 23, 2025 | -0.08 | — | — |
| Oct 24, 2024 | -0.04 | — | — |
| Aug 28, 2024 | -0.07 | — | — |
| Apr 23, 2024 | -0.02 | — | — |